Financials in USD. Standardized financial statements.
A compact view of how Heat Biologics, Inc. turns revenue into operating income and net income.
| Metric | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $2.11M | $2.95M | $3.05M | $5.79M | $1.52M | $341,643 | $0 | $0 | $0 | $3,110 |
| Revenue Growth? | -28.3% | -3.3% | -47.4% | +281.2% | +344.9% | 0.0% | 0.0% | 0.0% | -100.0% | 0.0% |
| Cost of Revenue? | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit? | $2.11M | $2.95M | $3.05M | $5.79M | $1.52M | $341,643 | $0 | $0 | $0 | $3,110 |
| Gross Margin? | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% | 0.0% | 0.0% | 0.0% | +100.0% |
| Operating Expenses? | $37.53M | $27.94M | $22.44M | $23.26M | $14.64M | $13.47M | $21.02M | $12.19M | $6.56M | $2.35M |
| Operating Income? | -$35.42M | -$26.12M | -$20.75M | -$17.96M | -$13.34M | -$13.13M | -$21.02M | -$12.19M | -$6.56M | -$2.34M |
| EBITDA? | -$35.55M | -$25.72M | -$19.74M | -$16.48M | -$12.52M | -$11.89M | -$19.82M | -$11.65M | -$8.63M | -$2.32M |
| Income Before Tax | -$35.55M | -$26.38M | -$20.34M | -$17.58M | -$13.22M | -$12.97M | -$21.12M | -$12.24M | -$6.61M | -$2.45M |
| Income Tax Expense | -$145,974 | -$257,027 | $45,178 | -$985,488 | -$809,540 | $701,923 | $264,000 | $17,070 | $33,896 | -$7,255 |
| Net Income? | -$35.40M | -$26.05M | -$20.02M | -$15.73M | -$11.84M | -$12.57M | -$20.30M | -$11.79M | -$8.71M | -$2.42M |
| EPS? | $-1.41 | $-1.63 | $-4.21 | $-6.30 | $-21.56 | $-49.40 | $-174.92 | $-126.18 | $-160.61 | $-90.87 |
| Diluted EPS? | $-1.41 | $-1.63 | $-4.21 | $-6.30 | $-21.56 | $-49.40 | $-174.92 | $-126.18 | $-160.61 | $-90.87 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality